Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nanovibronix Inc (NAOV)

Nanovibronix Inc (NAOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,516
  • Shares Outstanding, K 1,088
  • Annual Sales, $ 2,560 K
  • Annual Income, $ -3,710 K
  • EBIT $ -9 M
  • EBITDA $ -9 M
  • 60-Month Beta 2.05
  • Price/Sales 1.74
  • Price/Cash Flow N/A
  • Price/Book 0.10

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.55 +16.90%
on 11/21/25
5.36 -22.57%
on 11/25/25
-0.69 (-14.26%)
since 11/05/25
3-Month
3.55 +16.90%
on 11/21/25
17.40 -76.15%
on 09/15/25
-1.05 (-20.12%)
since 09/05/25
52-Week
3.55 +16.90%
on 11/21/25
162.50 -97.45%
on 04/08/25
-79.90 (-95.06%)
since 12/05/24

Most Recent Stories

More News
NanoVibronix Issues Letter to Shareholders

ENvue® Feeding Tube Placement System Identified as Core Growth Platform Strategic Rebranding and Name Change to Reflect Company’s Focus on Multi-Billion-Dollar Enteral-Feeding...

NAOV : 4.15 (+1.47%)
NanoVibronix Launches “Oscar” Training Aid to Accelerate ENvue Adoption and Unlock New Revenue Opportunities

Training platform accelerates onboarding, expands distribution potential and better positions Company for growth

NAOV : 4.15 (+1.47%)
NanoVibronix Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive therapeutic systems, today announced that it has entered into a definitive...

NAOV : 4.15 (+1.47%)
NanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical’s Intellectual Property Portfolio

Latest patent award strengthens competitive moat and reinforces leadership in medical navigation technology

NAOV : 4.15 (+1.47%)
NanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation Technology

Patent strengthens company’s leadership in feeding tube placement and opens path to broader vascular navigation market

NAOV : 4.15 (+1.47%)
NanoVibronix Announces Reverse Stock Split

Common Stock Will Begin Trading on Split-Adjusted Basis on August 12, 2025

NAOV : 4.15 (+1.47%)
NanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred Stock

Upfront $8 Million in Gross Proceeds and potential $40 million in Gross Proceeds from Exercise of Additional Investment Rights

NAOV : 4.15 (+1.47%)
NanoVibronix Issues Letter to Shareholders

NanoVibronix, Inc ., (NASDAQ: NAOV), a medical device company that produces the UroShield ® , PainShield ® and WoundShield ® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today...

NAOV : 4.15 (+1.47%)
NanoVibronix Receives Positive Final Results of Independent Lifecycle Testing of PainShield Prompted by Centers for Medicare and Medicaid Services (CMS)

NanoVibronix, Inc ., (NASDAQ: NAOV) (the “Company”), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (“SAW”) technology, today announced...

NAOV : 4.15 (+1.47%)
NanoVibronix Files Provisional U.S. Patent Application for UroShield Ultra

NanoVibronix, Inc ., (NASDAQ: NAOV) (the “Company”), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (“SAW”) technology, today announced...

NAOV : 4.15 (+1.47%)

Business Summary

NanoVibronix, Inc. is a medical device company. The Company's products include WoundShield(TM), a patch-based therapeutic ultrasound device which facilitates tissue regeneration and wound healing; PainShield(R), a disposable patch-based therapeutic ultrasound technology to treat pain, muscle spasm and...

See More

Key Turning Points

3rd Resistance Point 4.39
2nd Resistance Point 4.30
1st Resistance Point 4.23
Last Price 4.15
1st Support Level 4.07
2nd Support Level 3.98
3rd Support Level 3.91

See More

52-Week High 162.50
Fibonacci 61.8% 101.78
Fibonacci 50% 83.03
Fibonacci 38.2% 64.27
Last Price 4.15
52-Week Low 3.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar